Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Chronic Insomnia
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 21 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Neurophysiologic Maturation
Interventions: Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition; Other
Lead sponsor: Brown University; Other
Eligibility: 1 Day to 4 Days
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Detroit, Michigan • Providence, Rhode Island

Conditions: Hearing Loss, Cochlear Implant
Interventions: Electrocochleography; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 1 Year and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Heart Failure, Medication Compliance
Interventions: PROTEUS-SENSOR; Device
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Developmental Language Disorder, Healthy Subjects
Interventions: Supportive learning, Cascades; Behavioral
Lead sponsor: Father Flanagan's Boys' Home; Other
Eligibility: 5 Years to 10 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Asthma
Interventions: HXe MRI guided treatment sequence for BT, Standard treatment sequence for BT (control); Drug · Other
Lead sponsor: Xemed LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Colorectal Cancer, Advanced Adenocarcinoma
Interventions: Signal-C™; Device
Lead sponsor: Universal Diagnostics; Industry
Eligibility: 45 Years to 84 Years
Enrollment: 12,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Raonoke, Virginia

Conditions: Obstructive Sleep Apnea, Amyotrophic Lateral Sclerosis, Muscular Dystrophies, Healthy
Interventions: Transmembrane EMG Oropharynx Probe; Device
Lead sponsor: Powell Mansfield Inc.; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Epilepsy; Seizure, Sleep
Interventions: NextSense EEG-enabled earbuds; Device
Lead sponsor: NextSense, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chronic Pain
Interventions: EpiFaith™ Syringe, Conventional Loss-of-Resistance Syringe; Device
Lead sponsor: Flat Medical Co., Ltd; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: San Diego, California • Temecula, California

Conditions: Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Interventions: Lurbinectedin; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 2 Years to 30 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 15
States / cities: Los Angeles, California • Palo Alto, California • Washington D.C., District of Columbia + 12 more

Conditions: Burnout, Burnout, Healthcare Workers
Interventions: Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate, Real-time Biofeedback; Drug · Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Psoriasis
Interventions: IDP-118 Lotion, HP Monad Lotion, Ultravate Cream, Tazorac Cream; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 12
States / cities: Anaheim, California • Encino, California • San Diego, California + 9 more

Conditions: Stroke
Interventions: measuring cognitive flexibility including working memory and set-switching; Behavioral
Lead sponsor: Kai Hwang; Other
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Medical Adherence
Interventions: GlowCap, Daily email, text message, or phone call reminders, Paid for adherence; Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 84 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Depressive Disorder, Major
Interventions: Active neurofeedback, Sham neurofeedback; Behavioral
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 35 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Breast Cancer
Interventions: SAVI Scout MD system; Device
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Medication Adherence
Interventions: ID Capsule, Riboflavin, Prompts; Other · Dietary Supplement · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Alcohol Use Disorder
Interventions: Cervical transcutaneous vagus nerve stimulation (active comparator), Cervical transcutaneous vagus nerve stimulation (sham comparator); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Coronary Artery Disease
Interventions: Phase Signal Recorder; Device
Lead sponsor: Analytics For Life; Industry
Eligibility: 21 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Cumming, Georgia

Conditions: Melanoma, Neoplasm Metastasis
Interventions: GP100 peptide, IL-2; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson's Disease
Interventions: Activa PC+S; Device
Lead sponsor: Colorado Neurological Institute; Other
Eligibility: 21 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Mouth Neoplasms, Head and Neck Neoplasms, Tongue Neoplasms, Carcinoma, Squamous Cell
Interventions: Sirolimus; Drug
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Autonomic Failure, Pure Autonomic Failure, Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies
Interventions: [18F]FDOPA, Carbidopa 200mg oral dose, Entacapone 400mg oral dose; Drug
Lead sponsor: Daniel Claassen; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Hyper-Arousal in Chronic Primary Insomnia

Neurophysiologic Maturation Index for Late Preterm Infants

AB-Intra- and Post-Operative Measures of Auditory Function

Monitoring Medication Adherence in Left Ventricular Assist Device Recipients

The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder

Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI

A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Earbud EEG Feasibility Study

Clinical Evaluation of the EpiFaith™ Syringe in Epidural Pain Management

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Cognitive Control Functions of the Human Thalamus

GlowCaps Adherence Randomized Control Trial

Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression

Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery

Smart Capsule for Automatic Adherence Monitoring

Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder

Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

LFP Correlates of Movement Disorders

Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma

[18F]F-DOPA Imaging in Patients With Autonomic Failure